ReproCELL Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY32.1 |
Market Cap |
JPY16.17 B |
Shares Outstanding |
70.91 M |
Public Float |
66.71 M |
Address |
KDX Shin-Yokohama 381 Building, 9/F Yokohama Kanagawa 222 Japan |
Employees | - |
Website | http://www.reprocell.com |
Updated | 09/14/2018 |
ReproCELL Inc. engages in the development of diverse products with an underlying theme that focuses on stem cell technology. It operates through the following business divisions: Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells and Clinical Testing. The Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells division handles the manufacture and sale of research reagents, and the production and evaluation of cells. |